Taysha Gene Therapies Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.02

-0.14 (-2.71%)

As of Sep 20, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,112.4% upside

Low Target $45.99

Average Target $60.86

High Target $68.15

Current Price $5.02

Current
$5.02

Target
$60.86

$45.99 $60.86 avg $68.15

Scenario Analysis

Bear Case

$45.99

816.1%

Low target

Base Case

$60.86

+1,112.4%

Avg target

Bull Case

$68.15

+1,257.6%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$7.30

-31.2% from high

52-Week Low

$2.71

+85.2% from low

Target vs 52W High

$60.86

+733.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%